Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. covers the month of August 2021. The document reports on the status of the Company's Annual General Meeting of Shareholders convened on August 3, 2021.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The primary event noted is the adjournment of the Annual General Meeting due to a lack of quorum.
Outlook and Management Commentary
Management has announced that the Annual General Meeting, originally scheduled for August 3, 2021, was adjourned for one week. The meeting will be reconvened on Tuesday, August 10, 2021, at 3:00 p.m. (Israel time) at the Company's executive offices in Rehovot, Israel. The filing notes that this Form 6-K is incorporated by reference into the Company's registration statements on Form F-3 and Form S-8.
Key Facts for Investor Verification
- The Annual General Meeting was adjourned on August 3, 2021, due to a lack of quorum.
- The reconvened meeting is scheduled for August 10, 2021, at 3:00 p.m. Israel time.
- This filing contains no financial performance data or updated guidance.
- The document is incorporated by reference into existing registration statements (Form F-3 and Form S-8).